In our study, after adjusting for indicators of metabolic abnormalities (energy intake, insulin, glucose, and lipids; Supplementary Table 2, model 5) and metabolic diseases (hypertension and diabetes), a high risk of depressive symptoms is also observed in patients with severe sleep midpoint change. This evidence concerns the gene INS and metabolic disease.